Cross-domain correlates of cannabis use disorder severity among young adults.

Addict Behav

Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, United States; Harvard Medical School, Boston, MA, United States.

Published: June 2019

Background: Correlates of cannabis use and dependence among young adults have been widely studied. However, it is not known which factors are most strongly associated with severity of cannabis use dependence (CUD) severity. Identification of the salient correlates of CUD severity will be of increasing clinical significance as use becomes more socially normative.

Methods: This study used a data-driven, hypothesis-free approach to examine the most robust correlates of CUD severity among a sample of 76 young adults (ages 18 to 25 years) who used cannabis at least weekly. Seventy-one candidate variables were examined for association with CUD severity. These included demographic variables, self-reported and psychodiagnostic assessments of mood and anxiety, self-reported measures of personality, cannabis and other substance use characteristics, and objective and subjective measures of cognition.

Results: Of the 71 candidate variables considered, 27 were associated with CUD severity on a univariate level at a p-value ≤.20. Correlates of CUD severity in the multivariable model using stepwise selection were: more frequent cannabis use in the past 90 days, greater expectancies that cannabis causes cognitive and behavioral impairment, greater self-reported metacognitive deficits, greater anxiety, and lower reaction time variability on a test of sustained attention. Internal validation tests support high prediction accuracy of all variables in the multivariable model, except for lower reaction time variability.

Conclusions: Cannabis use frequency, beliefs about use, perceived cognitive abilities, and anxiety are robustly associated with CUD severity in young adult, regular cannabis users, and may be important in guiding prevention and treatment efforts.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920664PMC
http://dx.doi.org/10.1016/j.addbeh.2019.01.029DOI Listing

Publication Analysis

Top Keywords

cud severity
28
young adults
12
correlates cud
12
cannabis
9
severity
9
correlates cannabis
8
severity young
8
cannabis dependence
8
candidate variables
8
associated cud
8

Similar Publications

Article Synopsis
  • Cocaine use disorder (CUD) is a major public health issue, and there's currently no FDA-approved medication to treat it, highlighting the need for new treatments.
  • RDS04-010, a novel atypical dopamine transporter inhibitor, shows promise in animal models by significantly reducing cocaine-seeking behavior without producing addictive effects, unlike its analog RDS03-094 which has more cocaine-like properties.
  • The study’s results emphasize the importance of the binding conformation to the dopamine transporter and suggest RDS04-010 could be a potential therapeutic option for CUD due to its ability to lower motivation for cocaine use.
View Article and Find Full Text PDF
Article Synopsis
  • * A machine learning approach found that combining the SN and CEN provided a high accuracy of 73.4% in distinguishing CUD patients from healthy controls, indicating their importance in addiction stages over the DMN.
  • * Connectivity analysis showed reduced connectivity in the DMN and SN but increased connectivity in the CEN among CUD patients, suggesting these changes could be potential biomarkers for the severity of addiction.
View Article and Find Full Text PDF

Background: The dual diagnosis of cannabis use disorder (CUD) and severe mental disorder (SMD) results in clinically complex individuals. Cannabis use is known to have negative consequences on psychiatric symptoms, medication compliance, and disease prognosis. Moreover, the effectiveness of currently available psychotherapeutic treatments is limited in this population.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the risks of cannabis use disorder (CUD) among daily consumers in the U.S., focusing on the relationship between the amount of delta-9-tetrahydrocannabinol (THC) consumed daily and CUD severity.
  • - A large sample of 4,134 adult participants provided data through an online survey assessing cannabis consumption patterns and CUD criteria, leading to an average daily consumption of about 130 mgTHC.
  • - Results indicated that higher daily THC intake was linked to more severe CUD, with 65% of participants meeting CUD criteria—39% with mild, 18% with moderate, and 8% with severe cases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!